Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services within the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions.
Latest action · Nov 8, 2007 Referred to the Subcommittee on Health.
Progress
Where this resolution reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedSep 27, 2007
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Disapproves a specified rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions.
Declares that such rule shall have no force or effect.
Cosponsors 105
Members who signed on, in the order they did. Signatures ran from Sep 27, 2007 to Feb 7, 2008; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-MI | Mike Rogers | Original | Sep 27, 2007 |
| D-NY | Edolphus Towns | Oct 4, 2007 | |
| R-IL | Jerry Weller | Oct 4, 2007 | |
| R-TX | Pete Sessions | Oct 4, 2007 | |
| R-KY | Ron Lewis | Oct 4, 2007 | |
| D-GA | Sanford D. Bishop, Jr. | Oct 4, 2007 | |
| R-MI | Tim Walberg | Oct 4, 2007 | |
| D-MI | Dale E. Kildee | Oct 12, 2007 | |
| R-NJ | Frank A. LoBiondo | Oct 12, 2007 | |
| R-KY | Geoff Davis | Oct 12, 2007 | |
| D-CA | Howard L. Berman | Oct 12, 2007 | |
| D-PA | Jason Altmire | Oct 12, 2007 | |
| D-NY | Jerrold Nadler | Oct 12, 2007 | |
| D-CO | John T. Salazar | Oct 12, 2007 | |
| D-NY | Joseph Crowley | Oct 12, 2007 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Sep 27, 2007 |
| Health Subcommittee | Referred Nov 8, 2007 | |
| House | Ways and Means Committee | Referred Sep 27, 2007 |
| Health Subcommittee | Referred Oct 3, 2007 |
Actions 4
Everything that happened, newest first.
- Nov 8, 2007Referred to the Subcommittee on Health.
- Oct 3, 2007Referred to the Subcommittee on Health.
- Sep 27, 2007Introduced in House
- Sep 27, 2007Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Related bills 1
Companion bills and other measures the record links to this one.
Titles 1
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services within the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions.
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Sep 27, 2007Introduced in House
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this resolution on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.